Skip Navigation


Glycobiology Advance Access originally published online on January 12, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/4/17R    most recent
cwh051v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Powell, A. K.
Right arrow Articles by Turnbull, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powell, A. K.
Right arrow Articles by Turnbull, J. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology vol 14 no 4 pp. 17R-30R, 2004
Glycobiology vol. 14 no. 4 © Oxford University Press 2004; all rights reserved.


REVIEW

Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and experimental approaches

Andrew K. Powell1, Edwin A. Yates, David G. Fernig and Jeremy E. Turnbull

School of Biological Sciences, Biosciences Building, University of Liverpool, Crown Street, Liverpool, L69 7ZB, United Kingdom

Received on July 3, 2003; accepted on December 19, 2003

Over the past decade, the glycosaminoglycans heparin and heparan sulfate have been shown to bind and regulate the activities of many proteins. Established techniques have provided both qualitative and quantitative information regarding these interactions, leading to a general view that proteins bind with a variety of affinities to particular sequences within heparin or heparan sulfate chains. The mechanism by which heparan sulfate regulates the activity of proteins through such interactions has, however, proved more elusive. We survey some relevant details of the structural characteristics of heparin/heparan sulfate and the approaches used to investigate their interactions with proteins. For the latter, the interactions of heparin/heparan sulfate with fibroblast growth factors and their receptors will be emphasized, because these proteins have been the subject of many studies. We reflect on the information that various techniques have provided, points regarding their use, and some relevant theoretical considerations regarding the study of protein–heparin/heparan sulfate interactions. A perspective of new and developing approaches, which may aid advances in this field, is also provided.

1 To whom correspondence should be addressed; e-mail: andrew.powell{at}liverpool.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
M. M. Hossain, T. Hosono-Fukao, R. Tang, N. Sugaya, T. H van Kuppevelt, G. J Jenniskens, K. Kimata, S. D Rosen, and K. Uchimura
Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88
Glycobiology, February 1, 2010; 20(2): 175 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Thompson, D. G. Fernig, E. C. Jesudason, P. D. Losty, E. M. A. van de Westerlo, T. H. van Kuppevelt, and J. E. Turnbull
Heparan Sulfate Phage Display Antibodies Identify Distinct Epitopes with Complex Binding Characteristics: INSIGHTS INTO PROTEIN BINDING SPECIFICITIES
J. Biol. Chem., December 18, 2009; 284(51): 35621 - 35631.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Kalia, V. Chandra, S. A. Rahman, D. Sehgal, and S. Jameel
Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection
J. Virol., December 15, 2009; 83(24): 12714 - 12724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Wittrup, S.-H. Zhang, G. B. ten Dam, T. H. van Kuppevelt, P. Bengtson, M. Johansson, J. Welch, M. Morgelin, and M. Belting
ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles: EVIDENCE FOR HEPARAN SULFATE EPITOPE SPECIFICITY AND ROLE OF BOTH SYNDECAN AND GLYPICAN
J. Biol. Chem., November 20, 2009; 284(47): 32959 - 32967.
[Abstract] [Full Text] [PDF]


Home page
J R Soc InterfaceHome page
T. M. Puvirajesinghe, S. E. Guimond, J. E. Turnbull, and S. Guenneau
Chemometric analysis for comparison of heparan sulphate oligosaccharides
J R Soc Interface, November 6, 2009; 6(40): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
L. Jin, M. Hricovini, J. A Deakin, M. Lyon, and D. Uhrin
Residual dipolar coupling investigation of a heparin tetrasaccharide confirms the limited effect of flexibility of the iduronic acid on the molecular shape of heparin
Glycobiology, November 1, 2009; 19(11): 1185 - 1196.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Ori, P. Free, J. Courty, M. C. Wilkinson, and D. G. Fernig
Identification of Heparin-binding Sites in Proteins by Selective Labeling
Mol. Cell. Proteomics, October 1, 2009; 8(10): 2256 - 2265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Guimond, T. M. Puvirajesinghe, M. A. Skidmore, I. Kalus, T. Dierks, E. A. Yates, and J. E. Turnbull
Rapid Purification and High Sensitivity Analysis of Heparan Sulfate from Cells and Tissues: TOWARD GLYCOMICS PROFILING
J. Biol. Chem., September 18, 2009; 284(38): 25714 - 25722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. V. Victor, T. K. N. Nguyen, M. Ethirajan, V. M. Tran, K. V. Nguyen, and B. Kuberan
Investigating the Elusive Mechanism of Glycosaminoglycan Biosynthesis
J. Biol. Chem., September 18, 2009; 284(38): 25842 - 25853.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Ashikari-Hada, H. Habuchi, N. Sugaya, T. Kobayashi, and K. Kimata
Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate
Glycobiology, June 1, 2009; 19(6): 644 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mitsi, K. Forsten-Williams, M. Gopalakrishnan, and M. A. Nugent
A Catalytic Role of Heparin within the Extracellular Matrix
J. Biol. Chem., December 12, 2008; 283(50): 34796 - 34807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Hanoulle, A. Melchior, N. Sibille, B. Parent, A. Denys, J.-M. Wieruszeski, D. Horvath, F. Allain, G. Lippens, and I. Landrieu
Structural and Functional Characterization of the Interaction between Cyclophilin B and a Heparin-derived Oligosaccharide
J. Biol. Chem., November 23, 2007; 282(47): 34148 - 34158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Schenauer, Y. Yu, M. D. Sweeney, and J. A. Leary
CCR2 Chemokines Bind Selectively to Acetylated Heparan Sulfate Octasaccharides
J. Biol. Chem., August 31, 2007; 282(35): 25182 - 25188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. de Barros, L. R. Andrade, S. Allodi, C. Viskov, P. A. Mourier, M. C. M. Cavalcante, A. H. Straus, H. K. Takahashi, V. H. Pomin, V. F. Carvalho, et al.
The Hemolymph of the Ascidian Styela plicata (Chordata-Tunicata) Contains Heparin inside Basophil-like Cells and a Unique Sulfated Galactoglucan in the Plasma
J. Biol. Chem., January 19, 2007; 282(3): 1615 - 1626.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ricard-Blum, M. Beraud, N. Raynal, R. W. Farndale, and F. Ruggiero
Structural Requirements for Heparin/Heparan Sulfate Binding to Type V Collagen
J. Biol. Chem., September 1, 2006; 281(35): 25195 - 25204.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. Kreuger, D. Spillmann, J.-p. Li, and U. Lindahl
Interactions between heparan sulfate and proteins: the concept of specificity
J. Cell Biol., July 31, 2006; 174(3): 323 - 327.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Rubio-Gayosso, S. H. Platts, and B. R. Duling
Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Robinson, N. J. Harmer, S. J. Goodger, T. L. Blundell, and J. T. Gallagher
Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes
J. Biol. Chem., December 23, 2005; 280(51): 42274 - 42282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yu, M. D. Sweeney, O. M. Saad, S. E. Crown, T. M. Handel, and J. A. Leary
Chemokine-Glycosaminoglycan Binding: SPECIFICITY FOR CCR2 LIGAND BINDING TO HIGHLY SULFATED OLIGOSACCHARIDES USING FTICR MASS SPECTROMETRY
J. Biol. Chem., September 16, 2005; 280(37): 32200 - 32208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-C. Lee, H.-H. Guan, C.-H. Wang, W.-N. Huang, S.-C. Tjong, C.-J. Chen, and W.-g. Wu
Structural Basis of Citrate-dependent and Heparan Sulfate-mediated Cell Surface Retention of Cobra Cardiotoxin A3
J. Biol. Chem., March 11, 2005; 280(10): 9567 - 9577.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.